(secondQuint)Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients.

 The study enrolls 90 transplant recipients with positive nasal/throat culture specimens for Respiratory Syncytial Virus (RSV) infection.

 Patients are randomized into one of two groups: investigational treatment or standard treatment.

.

 Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients@highlight

The purpose of this study is to test the safety and effectiveness of ribavirin, administered as an aerosol, in preventing progression of upper respiratory tract RSV infection to RSV pneumonia in bone marrow and peripheral blood transplant recipients.

